SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-402003
Filing Date
2014-11-07
Accepted
2014-11-07 06:05:53
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d782395d10q.htm 10-Q 479846
2 EX-31.1 d782395dex311.htm EX-31.1 6298
3 EX-31.2 d782395dex312.htm EX-31.2 6315
4 EX-32.1 d782395dex321.htm EX-32.1 3205
5 EX-32.2 d782395dex322.htm EX-32.2 3223
  Complete submission text file 0001193125-14-402003.txt   3368638

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT idra-20140930.xml EX-101.INS 369443
7 XBRL TAXONOMY EXTENSION SCHEMA idra-20140930.xsd EX-101.SCH 49330
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE idra-20140930_cal.xml EX-101.CAL 57886
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE idra-20140930_def.xml EX-101.DEF 119411
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE idra-20140930_lab.xml EX-101.LAB 287654
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idra-20140930_pre.xml EX-101.PRE 206443
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 141202600
SIC: 2836 Biological Products, (No Diagnostic Substances)